Sébastien Czernichow, Daniel Thomas, Eric Bruckert
Index: Br. J. Nutr. 104 , 788-796, (2010)
Full Text: HTML
n-6 PUFA are well known for their critical role in many physiological functions and seem to reduce risks of CHD. However, some argue that excessive consumption of n-6 PUFA may lead to adverse effects on health and therefore recommend reducing dietary n-6 PUFA intake or fixing an upper limit. In this context, the present work aimed to review evidence on the link between n-6 PUFA and risks of CVD. Epidemiological studies show that n-6 PUFA dietary intake significantly lowers blood LDL-cholesterol levels. In addition, n-6 PUFA intake does not increase several CVD risk factors such as blood pressure, inflammatory markers, haemostatic parameters and obesity. Data from prospective cohort and interventional studies converge towards a specific protective role of dietary n-6 PUFA intake, in particular linoleic acid, against CVD. n-6 PUFA benefits are even increased when SFA intake is also reduced. In regards to studies examined in this narrative review, recommendation for n-6 PUFA intake above 5 %, and ideally about 10 %, of total energy appears justified.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
VITAMIN F
CAS:11006-87-4 |
Omega-3 fatty acids and metabolic syndrome: effects and emer...
2011-10-01 [Prog. Lipid Res. 50 , 372-387, (2011)] |
Fish oil and omega-3 fatty acids in cardiovascular disease: ...
2012-02-01 [Eur. Heart J. 33(4) , 436-43, (2011)] |
The effects of polyunsaturated fatty acids (PUFAs) on the sl...
1988-01-01 [Endocrinology 26 , 155-158, (1988)] |
Developmentally dependent and different roles of fatty acids...
2011-01-01 [Prague Med. Rep. 112 , 81-92, (2011)] |
[Essential unsaturated fatty acids].
1999-10-01 [Nihon Rinsho. 57 , 2242-2246, (1999)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved